Study limitation: No control group: pre-post changes should not be interpreted as evidence of efficacy; regression to the mean and concurrent medication (55% of participants) are major confounders | ReachRx
Metacognitive Training (MCT-Silver) for Older Adults with Depressive Symptoms in Portugal: A Pilot Study
Study limitation reported by the research below: “No control group: pre-post changes should not be interpreted as evidence of efficacy; regression to the mean and concurrent medication (55% of participants) are major confounders.”
